Intermediate chains of exopolysaccharides from Lactobacillus rhamnosus RW-9595M increase IL-10 production by macrophages

被引:164
作者
Bleau, C. [1 ]
Monges, A. [1 ]
Rashidan, K. [1 ]
Laverdure, J. -P. [1 ]
Lacroix, M. [2 ]
Van Calsteren, M. -R. [3 ]
Millette, M. [2 ]
Savard, R. [1 ]
Lamontagne, L. [1 ]
机构
[1] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada
[2] INRS Inst Armand Frappier, Res Lab Sci Appl Food, Laval, PQ, Canada
[3] Agr & Agroalimentaire Canada, Ctr Rech & Dev Aliments, St Hyacinthe, PQ, Canada
关键词
cytokines; exopolysaccharides; Lactobacillus; lymphocytes; macrophages; CLOSTRIDIUM-DIFFICILE COLITIS; TNF-ALPHA PRODUCTION; LIPOTEICHOIC ACID; IFN-GAMMA; T-CELLS; INTERLEUKIN-10; PROBIOTICS; STRAINS;
D O I
10.1111/j.1365-2672.2009.04450.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
Aims: To evaluate the immunosuppressive properties of the exopolysaccharide (EPS) from high-EPS producer Lactobacillus rhamnosus RW-9595M on inflammatory cytokines produced by macrophages. Methods and Results: The conditioned media (CM) were produced by macrophages treated with parental Lact. rhamnosus ATCC 9595 and its isogenic variant, the high-EPS producer Lact. rhamnosus RW-9595M, and the levels of TNF-alpha, IL-6, IL-10 and IL-12 were evaluated. Results revealed that CM from parental Lact. rhamnosus induced higher levels of TNF-alpha, IL-6 and IL-12 but inhibited IL-10 production, whereas its mucous variant induced low or no TNF-alpha and IL-6. Addition of purified EPS to macrophages treated with parental Lact. rhamnosus decreased the inflammatory cytokines and inhibited the metabolic activity of lymphocytes. The intermediate polysaccharide chains (16-30 units) produced by time-controlled hydrolysis of EPS increased the IL-10 produced by macrophages. Conclusions: Polysaccharide chains of EPS induced immunosuppression by the production of macrophagic anti-inflammatory IL-10. Significance and impact of the Study: These results indicate that the EPS from Lact. rhamnosus RW-9595M may be useful as a new immunosuppressive product in dairy food.
引用
收藏
页码:666 / 675
页数:10
相关论文
共 32 条
[1]
In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease [J].
Autschbach, F ;
Braunstein, J ;
Helmke, B ;
Zuna, I ;
Schürmann, G ;
Niemir, ZI ;
Wallich, R ;
Otto, HF ;
Meuer, SC .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (01) :121-130
[2]
TREATMENT OF RECURRENT CLOSTRIDIUM-DIFFICILE COLITIS WITH LACTOBACILLUS GG [J].
BILLER, JA ;
KATZ, AJ ;
FLORES, AF ;
BUIE, TM ;
GORBACH, SL .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (02) :224-226
[3]
Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function [J].
Braat, H ;
van den Brande, J ;
van Tol, E ;
Hommes, D ;
Peppelenbosch, M ;
van Deventer, S .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (06) :1618-1625
[4]
T cells of the human intestinal lamina propria are high producers of interleukin-10 [J].
Braunstein, J ;
Qiao, L ;
Autschbach, F ;
Schurmann, G ;
Meuer, S .
GUT, 1997, 41 (02) :215-220
[5]
USE OF AN AQUEOUS SOLUBLE TETRAZOLIUM FORMAZAN ASSAY TO MEASURE VIABILITY AND PROLIFERATION OF LYMPHOKINE-DEPENDENT CELL-LINES [J].
BUTTKE, TM ;
MCCUBREY, JA ;
OWEN, TC .
JOURNAL OF IMMUNOLOGICAL METHODS, 1993, 157 (1-2) :233-240
[6]
CARBON SOURCE REQUIREMENTS FOR EXOPOLYSACCHARIDE PRODUCTION BY LACTOBACILLUS-CASEI CG11 AND PARTIAL STRUCTURE-ANALYSIS OF THE POLYMER [J].
CERNING, J ;
RENARD, CMGC ;
THIBAULT, JF ;
BOUILLANNE, C ;
LANDON, M ;
DESMAZEAUD, M ;
TOPISIROVIC, L .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1994, 60 (11) :3914-3919
[7]
CERNING J, 1990, FEMS MICROBIOL LETT, V87, P113, DOI 10.1111/j.1574-6968.1990.tb04883.x
[8]
Chabot S, 2001, LAIT, V81, P683, DOI 10.1051/lait:2001157
[9]
Heteropolysaccharides from lactic acid bacteria [J].
De Vuyst, L ;
Degeest, B .
FEMS MICROBIOLOGY REVIEWS, 1999, 23 (02) :153-177
[10]
Biotherapeutic agents - A neglected modality for the treatment and prevention of selected intestinal and vaginal infections [J].
Elmer, GW ;
Surawicz, CM ;
McFarland, LV .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11) :870-876